Medycyna Wieku Rozwojowego

792
Katarzyna Drabko i wsp.
2. Apperley J., Carreras E., Glucman E., Gratwohl A., Masszi T.: Stem cell transplantation in
Children, Hematopoetic Stem Cell Transplantation. Forum Service Editore, Genoa Italy 2004.
3. Madero L., Munoz A., Sanchez de Toledo J., Diaz M.A., Maldonado M.S., Ortega J.J., Ramirez
M., Otheo E., Benito A., Salas S.: Megatherapy in Children with high risk Ewing’s sarcoma
in first complete remission. Bone Marrow Transplant 1998, 21, 795-799.
4. Kessinger A., Sharp J.G.: The ways and hows of hematopoetic stem cell mobilization. Bone
Marroe Transpl., 2003, 31, 319-329.
5. Gonzales I., Andreu E.J., Panizo A., Ingres S., Fontalba A., Fernandez-Luna J.L., Gaboli M.,
Sierrasesumaga L., Martin-Algarra S., Pardo J., Prosper F., Alava E.: Imatinib inhibits proliferation
of ewing Tumor cells mediated by the stem cell factor/ KIT receptor pathway and sensitizes
cells to vincristine and doxorubin-induced apoptosis. Clin. Cancer. Research., 2004, 10(2),
751-761.
6. Nakamura M., Iwahashi M., Nakamori M., Ueda K., Ojima K., Naka T., Ishida K., Yamaue
H.: Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor
immunity: comparison with immunodominant peptide-pulsed DCs. Oncology., 2005,
68(2-3), 163-170.
7. Slavin S., Or R., Prighozina T., Gurevitch O., Aker M., Panighari S., Shapira M., Nagler A.:
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals
and man. Bone Marrow Transpl., 2000, 25, Suppl. 2, 54-57.
8. Lundqvist A., Childs R.: Allogeneic hematopoietic cell transplantation as immunotherapy
for solid tumors: current status and future directions. J. Immunother., 200, 28(4), 281-288.
Katarzyna Drabko
Oddzia∏ Przeszczepiania Szpiku
Kliniki Hematologii i Onkologii
Dzieci´cej Akademii Medycznej
w Lublinie
20-093 Lublin, ul. Chodêki 2